Literature DB >> 7796233

Changes in pulmonary artery pressure in infants with respiratory distress syndrome following treatment with Exosurf.

A H Hamdan1, N J Shaw.   

Abstract

The pulmonary artery pressure (PAP) changes were studied using Doppler echocardiography in preterm infants treated with an artificial surfactant (Exosurf) during the acute phase of respiratory distress syndrome (RDS). The ratio of pulmonary artery acceleration time to the right ventricular ejection time (AT:RVET), measured from the Doppler wave form, was determined in 38 infants before the first dose of Exosurf, at one and six hours after the first dose, immediately before the second dose of Exosurf, and at one, six, 12, 36, and 60 hours subsequently. The median AT:RVET ratio corrected for heart rate (AT:RVET(c)) increased significantly an hour after administration of the first dose of Exosurf from 0.330 (0.273-0.410) to 0.380 (0.303-0.445) and similarly an hour after the second dose from 0.426 (0.252-0.495) to 0.440 (0.373-0.500). These changes occurred against a steady increase in the median AT:RVET(c) over the first 72 hours. It is concluded that the reduction in PAP correlates well with clinical parameters of disease severity and raises questions regarding the mode of action of Exosurf.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796233      PMCID: PMC2528443          DOI: 10.1136/fn.72.3.f176

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  18 in total

1.  Postnatal circulatory adaptation in healthy term and preterm neonates.

Authors:  N J Evans; L N Archer
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

2.  Comparison of Doppler-determined elevated pulmonary arterial pressure with pressure measured at cardiac catheterization.

Authors:  R Martin-Duran; M Larman; A Trugeda; J A Vazquez de Prada; J Ruano; A Torres; A Figueroa; A Pajaron; F Nistal
Journal:  Am J Cardiol       Date:  1986-04-01       Impact factor: 2.778

3.  Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.

Authors:  W Long; T Thompson; H Sundell; R Schumacher; F Volberg; R Guthrie
Journal:  J Pediatr       Date:  1991-04       Impact factor: 4.406

4.  Doppler echocardiographic prediction of pulmonary arterial hypertension in congenital heart disease.

Authors:  D Kosturakis; S J Goldberg; H D Allen; C Loeber
Journal:  Am J Cardiol       Date:  1984-04-01       Impact factor: 2.778

5.  Doppler-derived systolic pulmonary artery pressure in acute neonatal respiratory distress syndrome.

Authors:  M P Seppänen; P O Kääpä; P O Kero; M Saraste
Journal:  Pediatrics       Date:  1994-05       Impact factor: 7.124

6.  Factors affecting use of the Doppler-determined time from flow onset to maximal pulmonary artery velocity for measurement of pulmonary artery pressure in children.

Authors:  G A Serwer; A G Cougle; J M Eckerd; B E Armstrong
Journal:  Am J Cardiol       Date:  1986-08-01       Impact factor: 2.778

7.  Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique.

Authors:  A Kitabatake; M Inoue; M Asao; T Masuyama; J Tanouchi; T Morita; M Mishima; M Uematsu; T Shimazu; M Hori; H Abe
Journal:  Circulation       Date:  1983-08       Impact factor: 29.690

8.  Prediction of peak pulmonary artery pressure by continuous-wave Doppler echocardiography in infants and children.

Authors:  T Akiba; M Yoshikawa; S Otaki; Y Kobayashi; M Nakasato; H Suzuki; T Sato
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

9.  Increased shunt through the patent ductus arteriosus after surfactant replacement therapy.

Authors:  R I Clyman; A Jobe; M Heymann; M Ikegami; C Roman; B Payne; F Mauray
Journal:  J Pediatr       Date:  1982-01       Impact factor: 4.406

10.  Doppler assessment of pulmonary artery pressure and extrapulmonary shunting in the acute phase of hyaline membrane disease.

Authors:  N J Evans; L N Archer
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

View more
  7 in total

1.  A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.

Authors:  H Walti; M Monset-Couchard
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

2.  Changes in pulmonary artery pressure in infants with respiratory distress syndrome after treatment with Exosurf.

Authors:  D Rogers
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-03       Impact factor: 5.747

3.  Indirect estimates of pulmonary artery pressure.

Authors:  P Kääpä; M Seppänen; P Kero
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

4.  Pulmonary artery pressure: early predictor of chronic lung disease in preterm infants.

Authors:  N V Subhedar; A H Hamdan; S W Ryan; N J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-01       Impact factor: 5.747

5.  The effects of surfactant on haemodynamics in hyaline membrane disease.

Authors:  J Skinner
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

6.  Echocardiographic assessment of early circulatory status in preterm infants with suspected intrauterine infection.

Authors:  M Murase; A Ishida
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-10-20       Impact factor: 5.747

7.  Pilot observational study on haemodynamic changes after surfactant administration in preterm newborns with respiratory distress syndrome.

Authors:  Francesca Vitali; Silvia Galletti; Arianna Aceti; Giulia Aquilano; Marianna Fabi; Anna Balducci; Giacomo Faldella
Journal:  Ital J Pediatr       Date:  2014-03-05       Impact factor: 2.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.